Clinical Trial Update: Bevacizumab/Doxorubicin/Radiation for Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating bevacizumab with doxorubicin and radiation for sarcoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Doxorubicin (doxorubicin)
• Radiation therapy

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Sarcoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING